192 related articles for article (PubMed ID: 9211494)
1. Islet hormone secretion in pancreatic cancer patients with diabetes.
Permert J; Larsson J; Fruin AB; Tatemoto K; Herrington MK; von Schenck H; Adrian TE
Pancreas; 1997 Jul; 15(1):60-8. PubMed ID: 9211494
[TBL] [Abstract][Full Text] [Related]
2. Early changes in islet hormone secretion in the hamster pancreatic cancer model.
Permert J; Herrington M; Kazakoff K; Pour PM; Adrian TE
Teratog Carcinog Mutagen; 2001; 21(1):59-67. PubMed ID: 11135321
[TBL] [Abstract][Full Text] [Related]
3. In vivo glucose-stimulated amylin secretion is increased in nondiabetic patients with pancreatic cancer.
Mäkimattila S; Hietaniemi K; Kiviluoto T; Timonen T; Yki-Järvinen H
Metabolism; 2001 Sep; 50(9):1036-42. PubMed ID: 11555835
[TBL] [Abstract][Full Text] [Related]
4. Examining the effects of hyperglycemia on pancreatic endocrine function in humans: evidence for in vivo glucotoxicity.
Solomon TP; Knudsen SH; Karstoft K; Winding K; Holst JJ; Pedersen BK
J Clin Endocrinol Metab; 2012 Dec; 97(12):4682-91. PubMed ID: 23043193
[TBL] [Abstract][Full Text] [Related]
5. Islet amyloid polypeptide in patients with pancreatic cancer and diabetes.
Permert J; Larsson J; Westermark GT; Herrington MK; Christmanson L; Pour PM; Westermark P; Adrian TE
N Engl J Med; 1994 Feb; 330(5):313-8. PubMed ID: 8277951
[TBL] [Abstract][Full Text] [Related]
6. Pancreatic cancer is associated with impaired glucose metabolism.
Permert J; Ihse I; Jorfeldt L; von Schenck H; Arnqvist HJ; Larsson J
Eur J Surg; 1993 Feb; 159(2):101-7. PubMed ID: 8098623
[TBL] [Abstract][Full Text] [Related]
7. Improved glucose metabolism after subtotal pancreatectomy for pancreatic cancer.
Permert J; Ihse I; Jorfeldt L; von Schenck H; Arnquist HJ; Larsson J
Br J Surg; 1993 Aug; 80(8):1047-50. PubMed ID: 8402064
[TBL] [Abstract][Full Text] [Related]
8. IAPP as a regulator of glucose homeostasis and pancreatic hormone secretion (review).
Karlsson E
Int J Mol Med; 1999 Jun; 3(6):577-84. PubMed ID: 10341286
[TBL] [Abstract][Full Text] [Related]
9. Morphometric studies in human pancreatic cancer argues against the etiological role of type 2 diabetes in pancreatic cancer.
Saruc M; Iki K; Pour PM
Histol Histopathol; 2010 Apr; 25(4):423-32. PubMed ID: 20183795
[TBL] [Abstract][Full Text] [Related]
10. The effect of hypophysectomy on pancreatic islet hormone and insulin-like growth factor I content and mRNA expression in rat.
Jevdjovic T; Maake C; Zwimpfer C; Krey G; Eppler E; Zapf J; Reinecke M
Histochem Cell Biol; 2005 Feb; 123(2):179-88. PubMed ID: 15812646
[TBL] [Abstract][Full Text] [Related]
11. Pancreas and gut hormone responses to oral glucose and intravenous glucagon in cystic fibrosis patients with normal, impaired, and diabetic glucose tolerance.
Lanng S; Thorsteinsson B; Røder ME; Orskov C; Holst JJ; Nerup J; Koch C
Acta Endocrinol (Copenh); 1993 Mar; 128(3):207-14. PubMed ID: 8480468
[TBL] [Abstract][Full Text] [Related]
12. Impaired beta-cell function, incretin effect, and glucagon suppression in patients with type 1 diabetes who have normal fasting glucose.
Greenbaum CJ; Prigeon RL; D'Alessio DA
Diabetes; 2002 Apr; 51(4):951-7. PubMed ID: 11916912
[TBL] [Abstract][Full Text] [Related]
13. Gastrointestinal growth factors and pancreatic islet hormones during postoperative IGF-I supplementation in man.
Leinsköld T; Adrian TE; Arnelo U; Larsson J; Permert J
J Endocrinol; 2000 Nov; 167(2):331-8. PubMed ID: 11054648
[TBL] [Abstract][Full Text] [Related]
14. Dissociated insulin and islet amyloid polypeptide secretion from isolated rat pancreatic islets cocultured with human pancreatic adenocarcinoma cells.
Wang F; Adrian TE; Westermark G; Gasslander T; Permert J
Pancreas; 1999 May; 18(4):403-9. PubMed ID: 10231847
[TBL] [Abstract][Full Text] [Related]
15. Elevated islet amyloid pancreatic polypeptide and proinsulin in lean gestational diabetes.
Kautzky-Willer A; Thomaseth K; Ludvik B; Nowotny P; Rabensteiner D; Waldhäusl W; Pacini G; Prager R
Diabetes; 1997 Apr; 46(4):607-14. PubMed ID: 9075800
[TBL] [Abstract][Full Text] [Related]
16. Regulation of islet hormone release and gastric emptying by endogenous glucagon-like peptide 1 after glucose ingestion.
Salehi M; Vahl TP; D'Alessio DA
J Clin Endocrinol Metab; 2008 Dec; 93(12):4909-16. PubMed ID: 18827000
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of insulin secretion, but normal peripheral insulin sensitivity, in a patient with a malignant endocrine pancreatic tumour producing high amounts of an islet amyloid polypeptide-like molecule.
Stridsberg M; Berne C; Sandler S; Wilander E; Oberg K
Diabetologia; 1993 Sep; 36(9):843-9. PubMed ID: 8405756
[TBL] [Abstract][Full Text] [Related]
18. Normal secretion and action of the gut incretin hormones glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide in young men with low birth weight.
Schou JH; Pilgaard K; Vilsbøll T; Jensen CB; Deacon CF; Holst JJ; Vølund A; Madsbad S; Vaag AA
J Clin Endocrinol Metab; 2005 Aug; 90(8):4912-9. PubMed ID: 15899957
[TBL] [Abstract][Full Text] [Related]
19. No correlation between insulin and islet amyloid polypeptide after stimulation with glucagon-like peptide-1 in type 2 diabetes.
Ahrén B; Gutniak M
Eur J Endocrinol; 1997 Dec; 137(6):643-9. PubMed ID: 9437230
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of impaired glucose-potentiated insulin secretion in diabetic 90% pancreatectomy rats. Study using glucagonlike peptide-1 (7-37).
Hosokawa YA; Hosokawa H; Chen C; Leahy JL
J Clin Invest; 1996 Jan; 97(1):180-6. PubMed ID: 8550831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
